Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryzodeg vs NovoMix 30 in Asian Patients With Type 2 Diabetes (BOOST: INTENSIFY ALL)
NCT01059812Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2010
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of insulin degludec + insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Feb 2010; status: completed.
02
Drugs
insulin degludec + insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01059812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059812.